Teva Pharmaceutical Industries Limited (TEVA) Announces Drug Development Investment in Cocrystal Discovery, Inc. for Novel Antiviral Therapeutics  
9/15/2011 10:19:13 AM

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has signed a collaboration option to license and share purchase agreements to invest in Cocrystal Discovery Inc. (CDI), a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases.